Verification of neuroprotective effects of alpha-lipoic acid on chronic neuropathic pain in a chronic constriction injury rat model

• Published in: Open life sciences Vol. 16; no. 1; pp. 222 - 228
• Main Authors: Wang, Junhao, Lou, Zhaohui, Xi, Haiyang, Li, Zhi, Li, Lepeng, Li, Zhenzhen, Zhang, Kai, Asakawa, Tetsuya
• Format: Journal Article
• Language: English
• Published: Poland De Gruyter 12.03.2021
• Subjects: alpha-lipoic acid; dorsal root ganglia; neuropathic pain; peripheral nerve injury; satellite glial cells; neuropathic pain; peripheral nerve injury; alpha-lipoic acid; dorsal root ganglia; satellite glial cells
• ISSN: 2391-5412; 2391-5412
• DOI: 10.1515/biol-2021-0026

Treatment of neuropathic pain is far from satisfactory. This study sought evidence of a neuroprotective effect of alpha-lipoic acid (ALA) to treat neuropathic pain in a chronic constriction injury (CCI) rat model. A total of 48 rats were randomly divided into sham, CCI, or CCI + ALA groups. Mechanical and thermal nociceptive thresholds were evaluated as behavioral assessments. Dorsal root ganglia cells were assessed morphologically with hematoxylin and eosin staining and for apoptosis with P53 immunohistochemical staining. Compared with the sham group, the CCI group had a shorter paw withdrawal threshold and paw withdrawal latency, abnormal morphologic manifestations, and increased numbers of satellite glial cells and P53+ cells. These changes were significantly reversed by treatment with ALA. Our study indicates neuroprotective effects of ALA on chronic neuropathic pain in a CCI rat model. ALA is potentially considered to be developed as a treatment for neuropathic pain caused by peripheral nerve injury, which requires further verification.